{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:45:20Z","timestamp":1787244320349,"version":"build-2736575974"},"reference-count":11,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2022,10,1]]},"DOI":"10.1001\/jamapsychiatry.2022.2032","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T11:32:24Z","timestamp":1661945544000},"page":"950","source":"Crossref","is-referenced-by-count":9,"title":["A Case for Permanent Adoption of Expanded Telehealth Services and Prescribing Flexibilities for Opioid Use Disorder"],"prefix":"10.1001","volume":"79","author":[{"given":"Mark \u00c9.","family":"Czeisler","sequence":"first","affiliation":[{"name":"Francis Weld Peabody Society, Harvard Medical School, Boston, Massachusetts"},{"name":"School of Psychological Sciences, Turner Institute for Brain and Mental Health, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"yed220006r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2284","article-title":"Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and during the COVID-19 pandemic.","author":"Jones","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"yed220006r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.23677","article-title":"Modeling mitigation strategies to reduce opioid-related morbidity and mortality in the US.","volume":"3","author":"Ballreich","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"yed220006r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019.","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"11","key":"yed220006r5","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamapsychiatry.2020.1511","article-title":"Methadone for opioid use disorder-decades of effectiveness but still miles away in the US.","volume":"77","author":"Joudrey","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"yed220006r6","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/jama.2021.1741","article-title":"Overcoming barriers to treatment of opioid use disorder.","volume":"325","author":"Olsen","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"yed220006r7","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1073\/pnas.90.12.5391","article-title":"A brief history of opiates, opioid peptides, and opioid receptors.","volume":"90","author":"Brownstein","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"yed220006r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.1776","article-title":"Methadone-involved overdose deaths in the us before and after federal policy changes expanding take-home methadone doses from opioid treatment programs.","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"yed220006r9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.31640","article-title":"Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic.","volume":"3","author":"Eberly","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"yed220006r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.42676","article-title":"Drug overdose mortality among people experiencing homelessness, 2003 to 2018.","volume":"5","author":"Fine","year":"2022","journal-title":"JAMA Netw Open"},{"key":"yed220006r2","unstructured":"US Centers for Disease Control and Prevention. Understanding the Epidemic. Accessed July 4, 2022. https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html"},{"key":"yed220006r11","unstructured":"US Centers for Disease Control and Prevention. Evidence-based strategies for preventing opioid overdose: what\u2019s working in the United States. Accessed July 6, 2022. https:\/\/www.cdc.gov\/drugoverdose\/featured-topics\/evidence-based-strategies.html"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2795954\/jamapsychiatry_czeisler_2022_ed_220006_1664208855.27011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T11:01:19Z","timestamp":1664967679000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2795954"}},"subtitle":["Insights From Pandemic-Prompted Emergency Authorities"],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.2032","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}